Publications by authors named "Christian Allan"
Neurotrophic corneal defects are difficult to heal and all too often lead to scarring and vision loss. Medical management is often of limited success. We describe the results of nine patients (ages 37-84) with chronic nonhealing neurotrophic corneal epithelial defects who were treated with thymosin beta 4 (Tbeta4) sterile eye drops for 28 or 49 days with a follow-up period of 30 days.
View Article and Find Full Text PDFArticle Synopsis
- Thymosin beta4 (Tbeta4) is a key molecule that helps regulate various cellular functions, including cell movement, blood vessel formation, and survival.
- Research supports its potential in clinical trials aimed at tissue protection and regeneration in fields like dermatology and cardiology.
- There’s a specific focus on using Tbeta4 in treating severe heart attacks, particularly in conjunction with coronary intervention techniques.